PROACTIVE-HF IDE Trial Heart Failure NYHA Class III (NCT04089059)
A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients compared to a Performance Goal (PG).
Who can join: Review the eligibility criteria below.
Location: Ascension St Vincent's — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (74 Sites)
Showing the first 25 of 74 sites.
- Ascension St Vincent's — Birmingham, Alabama
- Huntsville Hospital — Huntsville, Alabama
- Phoenix Cardiovascular Research Group/Insight — Phoenix, Arizona
- Loma Linda University — Loma Linda, California
- Eisenhower Medical Center — Rancho Mirage, California
- UCSD — San Diego, California
- Kaiser San Francisco — San Francisco, California
- UCSF Medical Center — San Francisco, California
- Kaiser Santa Clara — Santa Clara, California
- South Denver Cardiology — Littleton, Colorado
- Hartford Hospital — Hartford, Connecticut
- Baptist Health South Florida — Miami, Florida
- Ascension Sacred Heart — Pensacola, Florida
- USF Health — Tampa, Florida
- Cleveland Clinic — Weston, Florida
- Piedmont Athens — Athens, Georgia
- Queens Medical Center — Honolulu, Hawaii
- Northwestern — Chicago, Illinois
- U of Chicago — Chicago, Illinois
- Heart Centers of Illinois — Palos Park, Illinois
- OSF Healthcare — Peoria, Illinois
- Ascension St Vincent's — Indianapolis, Indiana
- University of Iowa Medical Center — Iowa City, Iowa
- University of Kansas Medical Center (KUMC) — Kansas City, Kansas
- University Of Louisville — Louisville, Kentucky
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure NYHA Class III
- Optimizing HFrEF Patients Using BaroStim and CardioMems — Riverhead, New York
- Sustaining Home Heart Failure Palliative Care in Rural Appalachia — Morgantown, West Virginia
- Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure — Naperville, Illinois
Explore by condition: All Heart Failure NYHA Class III clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.